Articles liés à Artificial Intelligence in Drug Development: Patenting...
- ÉditeurSpringer Nature
- Date d'édition2024
- ISBN 10 981972953X
- ISBN 13 9789819729531
- ReliureRelié
- Langueanglais
- Nombre de pages149
Acheter neuf
Afficher cet article
EUR 137,52
EUR 14,13 expédition depuis Royaume-Uni vers Etats-Unis
Destinations, frais et délaisRésultats de recherche pour Artificial Intelligence in Drug Development: Patenting...
Image d'archives
Artificial Intelligence in Drug Development: Patenting and Regulatory Aspects (Frontiers of Artificial Intelligence, Ethics and Multidisciplinary Applications)
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. In. N° de réf. du vendeur ria9789819729531_new
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
Artificial Intelligence in Drug Development
Edité par
Springer Nature Singapore Mai 2024, 2024
ISBN 10 : 981972953X
ISBN 13 : 9789819729531
Neuf
Couverture rigide
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book discusses how Artificial Intelligence developments have revolutionized the area of medicine and how companies use them to develop applications. While the book covers the growth of AI in medicine and the early developments in AI based medical tools, it provides an in-depth analysis of the current developments in relation to the area of medical diagnostics. The book focuses on how enterprises and institutes have developed their intellectual property portfolio, particularly patents, in this area. Cross-country patenting analysis helps in understanding key areas of growth in certain markets and also company strategies and arrangements. The introduction of AI based products in market is subject to regulation. The developments in policy and regulation influence the development and deployment of such products into the market. This book brings focus to the development of policy and regulation and how regulatory developments impact the introduction of AI-based healthcare products from a cross-country perspective. Further, how regulatory developments lead to the evolution of standards, build reliability and safety in this area are also examined. The unique aspect of this book is the comprehensive coverage of the dual aspects of the nature and scope of AI-based innovations in health care and the related drug regulatory aspects which are imperative for the understanding for students, researchers, and those who work in this area. 164 pp. Englisch. N° de réf. du vendeur 9789819729531
Quantité disponible : 2 disponible(s)
Image d'archives
Artificial Intelligence in Drug Development: Patenting and Regulatory Aspects (Frontiers of Artificial Intelligence, Ethics and Multidisciplinary Applications)
Vendeur : California Books, Miami, FL, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. N° de réf. du vendeur I-9789819729531
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
Artificial Intelligence in Drug Development
Edité par
Springer, Berlin|Springer Nature Singapore|Springer, 2024
ISBN 10 : 981972953X
ISBN 13 : 9789819729531
Neuf
Couverture rigide
Vendeur : moluna, Greven, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. This book discusses how Artificial Intelligence developments have revolutionized the area of medicine and how companies use them to develop applications. While the book covers the growth of AI in medicine and the early developments in AI based medical to. N° de réf. du vendeur 1571797721
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
Artificial Intelligence in Drug Development : Patenting and Regulatory Aspects
Edité par
Springer Nature Singapore, Springer Nature Singapore, 2024
ISBN 10 : 981972953X
ISBN 13 : 9789819729531
Neuf
Couverture rigide
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - This book discusses how Artificial Intelligence developments have revolutionized the area of medicine and how companies use them to develop applications. While the book covers the growth of AI in medicine and the early developments in AI based medical tools, it provides an in-depth analysis of the current developments in relation to the area of medical diagnostics. The book focuses on how enterprises and institutes have developed their intellectual property portfolio, particularly patents, in this area. Cross-country patenting analysis helps in understanding key areas of growth in certain markets and also company strategies and arrangements. The introduction of AI based products in market is subject to regulation. The developments in policy and regulation influence the development and deployment of such products into the market. This book brings focus to the development of policy and regulation and how regulatory developments impact the introduction of AI-based healthcare products from a cross-country perspective. Further, how regulatory developments lead to the evolution of standards, build reliability and safety in this area are also examined. The unique aspect of this book is the comprehensive coverage of the dual aspects of the nature and scope of AI-based innovations in health care and the related drug regulatory aspects which are imperative for the understanding for students, researchers, and those who work in this area. N° de réf. du vendeur 9789819729531
Quantité disponible : 1 disponible(s)
Image d'archives
Artificial Intelligence in Drug Development (Hardcover)
Edité par
Springer Verlag, Singapore, 2024
ISBN 10 : 981972953X
ISBN 13 : 9789819729531
Neuf
Couverture rigide
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Hardcover. Etat : new. Hardcover. This book discusses how Artificial Intelligence developments have revolutionized the area of medicine and how companies use them to develop applications. While the book covers the growth of AI in medicine and the early developments in AI based medical tools, it provides an in-depth analysis of the current developments in relation to the area of medical diagnostics. The book focuses on how enterprises and institutes have developed their intellectual property portfolio, particularly patents, in this area. Cross-country patenting analysis helps in understanding key areas of growth in certain markets and also company strategies and arrangements. The introduction of AI based products in market is subject to regulation. The developments in policy and regulation influence the development and deployment of such products into the market. This book brings focus to the development of policy and regulation and how regulatory developments impact the introduction of AI-based healthcare products from a cross-country perspective. Further, how regulatory developments lead to the evolution of standards, build reliability and safety in this area are also examined. The unique aspect of this book is the comprehensive coverage of the dual aspects of the nature and scope of AI-based innovations in health care and the related drug regulatory aspects which are imperative for the understanding for students, researchers, and those who work in this area. This book discusses how Artificial Intelligence developments have revolutionized the area of medicine and how companies use them to develop applications. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9789819729531
Quantité disponible : 1 disponible(s)
Image d'archives
Artificial Intelligence in Drug Development: Patenting and Regulatory Aspects
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Hardcover. Etat : Brand New. 162 pages. 9.25x6.10x9.21 inches. In Stock. N° de réf. du vendeur x-981972953X
Quantité disponible : 2 disponible(s)